Recently, a 60-year-old female patient with a giant intracranial aneurysm was admitted to Department of Neurosurgery of the First Affiliated Hospital of Xi’an Jiaotong University (XJTU). She reported chief complaints of blepharoptosis and eye movement disorder of her right eye for 7 months. Upon admission, cranial MRI examination revealed a giant intracranial aneurysm, approximately 27 mm×26 mm in size. After multi-disciplinary consultation, Director Zhang Hua chose the therapeutic regime of implanting blood flow-diverting device (Pipeline stent). On April 15, Chief Physician Xie Wanfu performed the surgery. The patient recovered well postoperatively and was discharged from hospital.
Pipeline stent is a low-porosity blood flow diversion device. Literature statistics demonstrate thatuse of Pipeline flow-diverting device has increased the cure rate of giant intracranial aneurysms to above 95%. To improve the cure rate, the team led by Chief Physician Xie Wanfu and Associate Chief Physician Bai Xiaobin from Department of Neurosurgery of our hospital have attempted to apply Pipeline flow-diverting device in the treatment of large and giant intracranial aneurysms since 2018. Up to now, the team has successfully completed more than 10 cases with high clinical efficacy and safety. This surgical method can reduce the difficulty and simplify the steps of the operation, minimize the risk of aneurysm wall rupture and hemorrhage caused by surgical procedures, and significantly enhance the long-term cure rate during follow-up.
The success of this case signifies that Department of Neurosurgery of our hospital has achieved international standards and levels in the endovascular interventional treatment of intracranial aneurysms.